Sunday 21 January 2018
Contact US    |    Archive
PR
4 months ago

Vanda s Tradipitant Improves Itch and Disease Severity in Patients with Atopic Dermatitis

WASHINGTON, Sept. 13, 2017 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA) today a

Read on the original site


هذه الصفحة هي مجرد قاریء تلقائي للأخبار باستخدام خدمة الـ RSS و بأن نشر هذه الأخبار هنا لاتعني تأییدها علی الإطلاق.
Hashtags:   

Vanda

 | 

Tradipitant

 | 

Improves

 | 

Itch

 | 

and

 | 

Disease

 | 

Severity

 | 

Patients

 | 

with

 | 
Most Popular (6 hours)

Festival in Dammam concluded

- Saudi News Agency

Most Popular (24 hours)

Most Popular (a week)

Categories - Countries
All News
All Countries